Integrated Traditional Chinese and Western medicine care for adults with obesity
Official title: Real-World Case Registry Study on Obesity
Run by Hubei Hospital of Traditional Chinese Medicine · NCT07448090 · Data updated 2026-11-12
This project will try combining traditional Chinese medicine and Western medical care in adults with obesity to see how well that combination works in everyday clinical practice.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Hubei Hospital of Traditional Chinese Medicine Academic / other |
| Locations | 1 site (Wuhan, Hubei) |
| Status | Recruiting |
| Started | August 31, 2024 |
| Main results expected | July 31, 2028 |
| Study ends | July 31, 2028 |
| Registry record updated | June 12, 2026 |
| Trial ID | NCT07448090 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with BMI ≥ 28.0 kg/m2, weight fluctuation ≤ 5% in the prior 3 months, able to consent and comply with follow‑up, and without severe organ disease or secondary/iatrogenic obesity are appropriate candidates.
✕Probably not a fit
Patients with secondary or iatrogenic obesity, significant heart/liver/lung/kidney/brain or blood disorders, pregnant or breastfeeding women, or those the investigator deems unsuitable are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter, prospective, observational registry enrolling at least 10,000 adults with obesity from urban and rural populations in China. Participants receive routine clinical care without assigned interventions while researchers collect electronic medical records, laboratory tests, imaging, and lifestyle information. The registry will document real-world integrated TCM and Western medicine management and compare outcomes across age groups, disease stages, and TCM constitution types. Health economic analyses and disease progression pattern analyses will be performed to identify key prevention and treatment points.
Why it matters
Potential benefit: If successful, the project could help personalize obesity care by identifying effective, safe, and cost‑effective combinations of TCM and Western treatments.
How similar studies have gone: Smaller clinical and observational studies have suggested benefits from combining TCM and Western approaches for obesity, but high‑quality large-scale real-world evidence remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18 years and above, gender not restricted; 2. Weight fluctuation within the last 3 months is ≤ 5% and BMI is ≥ 28.0 kg/m2; 3. Good compliance, willing to follow the follow-up principles; 4. Agree to sign the informed consent form. Exclusion Criteria: 1. Co-existing severe diseases of the heart, liver, lungs, kidneys, brain, blood, neuro-psychiatric system, or other vital organs. 2. Secondary obesity (obesity attributable to another clearly diagnosed disorder, e.g., hypothalamic or pituitary inflammation, tumours or trauma, Cushing's syndrome, hypothyroidism, hypogonadism, polycystic ovary syndrome, etc.). 3. Iatrogenic obesity (obesity resulting from drugs or therapeutic interventions administered for other conditions). 4. Pregnant or lactating women. 5. Subjects whom the investigator deems unsuitable for participation in this study.
Where it's running
-
Hubei Provincial Hospital of Traditional Chinese Medicine
Wuhan, Hubei, China Recruiting
Study contacts
- Principal investigator: ChenGang ChenGang, Doctor — Hubei College of Traditional Chinese Medicine
- Study coordinator: ChenGang Professor ChenGang, Doctor
- Email: 250149875@qq.com
- Phone: +86 17720376888
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dramatherapy Added to Physical Activity for Obesity Care
This trial tests whether adding dramatherapy to a standard adapted physical activity program helps adults with obesity in bariatric or medical care improve psychosocial well‑being and weight-related outcomes.
-
Side-to-side duodeno-ileostomy with magnets versus semaglutide for adults with obesity and type 2 diabetes
This trial tests whether a magnet-assisted side-to-side duodeno-ileostomy surgery or the medication semaglutide works better to improve blood sugar control and weight in adults with obesity and type 2 diabetes.
-
Different weekly feedback messages to support weight loss
This project will test whether different weekly feedback messages delivered via a smartphone app help adults with overweight or obesity lose weight.
-
Weekly self-monitoring feedback and goal prompts to support weight loss
This trial will test different weekly feedback messages and goal prompts delivered by smartphone to see which help adults with overweight or obesity stick to tracking their diet, activity, and weight and lose more weight.
-
How incretin treatments affect muscle mass and function in people with overweight or obesity
This study will see how drugs like semaglutide and tirzepatide influence fat-free mass, muscle strength, and physical function in adults with overweight or obesity.
-
Dose find for remimazolam plus alfentanil for gastroscopy in obese adults
This trial tests what dose of remimazolam besylate with alfentanil best sedates obese adults during gastroscopy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.